Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 2 of 3: Mean cell count and mean normalized growth rate inhibition values across all replicates. - Dataset (ID:20257)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Nilotinib | 3.1623 | uM | 1 | 156.25 | 31.46 | 66.33 | 85.83 | 0.7995 | 0.7106 |
| MCF7 | Nilotinib | 1 | uM | 1 | 156.25 | 31.46 | 87.00 | 85.83 | 1.0164 | 1.0312 |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 5 | 156.25 | 28.48 | 91.67 | 86.83 | 1.0497 | 1.0493 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 156.25 | 28.48 | 110.67 | 86.83 | 1.2967 | 1.3720 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 156.25 | 28.48 | 100.67 | 86.83 | 1.1704 | 1.2160 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 156.25 | 28.48 | 86.00 | 86.83 | 1.0016 | 1.0117 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 156.25 | 28.48 | 91.33 | 86.83 | 1.0605 | 1.0747 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 156.25 | 28.48 | 85.67 | 86.83 | 0.9955 | 0.9972 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 156.25 | 28.48 | 102.33 | 86.83 | 1.1844 | 1.2252 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 156.25 | 28.48 | 107.00 | 86.83 | 1.2618 | 1.3295 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 156.25 | 28.48 | 98.67 | 86.83 | 1.1535 | 1.2017 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 156.25 | 28.48 | 637.00 | 86.83 | 7.4389 | 6.2182 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 156.25 | 28.48 | 819.33 | 86.83 | 9.3685 | 7.0475 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 156.25 | 28.48 | 99.67 | 86.83 | 1.1383 | 1.1515 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 156.25 | 28.48 | 98.33 | 86.83 | 1.1514 | 1.1935 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 156.25 | 28.48 | 129.67 | 86.83 | 1.4983 | 1.5847 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 156.25 | 28.48 | 104.67 | 86.83 | 1.2033 | 1.2423 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 156.25 | 28.48 | 126.00 | 86.83 | 1.4745 | 1.5674 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 156.25 | 28.48 | 85.33 | 86.83 | 1.0168 | 1.0306 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 156.25 | 28.48 | 107.33 | 86.83 | 1.2304 | 1.2616 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 156.25 | 28.48 | 77.67 | 86.83 | 0.9042 | 0.8855 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 156.25 | 28.48 | 114.00 | 86.83 | 1.3262 | 1.3987 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 156.25 | 28.48 | 93.67 | 86.83 | 1.0842 | 1.1102 |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 156.25 | 28.48 | 84.67 | 86.83 | 0.9830 | 0.9808 |
| SK-BR-3 | Etoposide | 3.1623 | uM | 5 | 156.25 | 28.48 | 83.67 | 86.83 | 0.9710 | 0.9608 |